FDA Approves New Drug to Fight Advanced Prostate Cancer
Xofigo was fast-tracked for approval and is meant for tumors that have spread to the bonesContinue Reading
Xofigo was fast-tracked for approval and is meant for tumors that have spread to the bonesContinue Reading
In study, more men on impotence meds were taking opioids for chronic back painContinue Reading
Discovery suggests interventions for reading disability need to be tailored accordinglyContinue Reading
Disease risk is strongly tied to family historyContinue Reading
But experts question the study’s design and are skeptical of the conclusionContinue Reading
Infertility clinics find that many men seeking help were taking ‘T’Continue Reading
While 1 in 8 has memory problems and confusion, too few seek helpContinue Reading
Xiaflex up for FDA approval later this year, but some experts think injections required would be a tough sellContinue Reading
Study finds slow, steady increase, but experts say condition remains uncommonContinue Reading
Most sellers extol benefits with little mention of potential health hazards, study findsContinue Reading
Men least likely to nod off were most likely to have severe disease, researchers foundContinue Reading
In study of 6 million ED patients, 75 percent either didn’t receive or fill prescriptionsContinue Reading
Most younger men and those over 70 don’t need prostate cancer screening; middle-aged men should talk with their doctorContinue Reading
Danish study found overweight males in their 20s had worse health in middle ageContinue Reading
© 2021 TheHealthCast.com - All Rights Reserved.